BEAM — Beam Therapeutics Inc.
No mentions collected in the last 24 hours.
BEAM — 오늘 왜 언급됐나 (2026-10-28)
- BEAM 테라퓨틱스는 글리코겐 저장병 1형에 대한 BEAM-301의 초기 1상/2상 데이터를 검토했다.
Why people talked about BEAM
- BEAM Therapeutics reviewed initial Phase I/II data for BEAM-301 in Glycogen Storage Disease Type 1a.
- BEAM was listed among the most shorted stocks over $1B, with a short interest of 32.3%.